YARD-FORCE
31.1.2024 02:51:31 CET | Business Wire | Press release
Yard Force takes a bold step forward with the introduction of the REVOLA robot lawn mower, challenging the norm in the Outdoor Power Equipment (OPE) market, with fully-featured and Virtual Boundary Technology. Recent data from Statista reveals that the OPE market reached a staggering $33.56 billion in 2022, with an anticipated Compound Annual Growth Rate (CAGR) of 5.6% from 2022 to 2027, projecting a market size of $44.07 billion. Lawn mowers, especially those integrating lithium-ion technology, are at the forefront of this growth, boasting an estimated CAGR of 9%, outpacing other OPE categories.
The REVOLA robot lawn mower from Yard Force emerges as a game-changer, not just as an efficient grass-cutting tool but as a solution to longstanding challenges in the industry. Packed with advanced technologies, the REVOLA promises users a unique and efficient lawn-mowing experience.
Key Features of the REVOLA Robot Lawn Mower:
1. Virtual Boundary Navigation System: The Virtual Boundary Navigation System in the REVOLA is called APNT (Advanced Positioning and Navigation Technology) leverages a multi-faceted approach to ensure accurate and reliable navigation. It utilizes satellite positioning for global location awareness, path planning algorithms for efficient route optimization, ultrasonic sensor for proximity sensing, and VSLAM (Visual Simultaneous Localization and Mapping) technology for real-time visual mapping and positioning. The VSLAM technology is a standout feature, allowing the REVOLA to create a dynamic map of its surroundings, navigate with precision, and adapt to changes in the environment. This technology plays a crucial role in overcoming obstacles, providing flexibility, and ensuring a robust navigation experience even in challenging conditions.
2. Addressing Existing Pain Points: The REVOLA addresses common challenges faced by traditional virtual boundary robot mowers. Unlike its counterparts, the REVOLA's VSLAM technology enables it to accurately cutting even though satellite signal is weak. Additionally, positioning inaccuracies caused by obstacles such as trees, houses, or electric poles are mitigated through the advanced VSLAM technology. This results in a seamless and trouble-free mowing experience for users, eliminating the frustrations associated with traditional navigation limitations.
3. Enhanced Safety Features: Safety is a top priority for the REVOLA, as validated by TÜV Rheinland tests. Traditional satellite-based mowers may face challenges with larger stones, potentially causing damage to blades or posing risks to objects like water pipes and toys. The REVOLA mitigates these risks through its intelligent obstacle recognition and detection system by integrated ultrasonic sensor and RGB camera. This system ensures that the mower can identify obstacles, including stones larger than 10 cm, and take appropriate actions to navigate around them, promoting a safe mowing process and protecting both the mower and the surrounding environment.
4. Optimized Battery Consumption Performance: The REVOLA is designed for efficient and long-lasting performance with its optimized battery consumption thanks to the systematic cut algorithm. Equipped with a powerful 28V 5.7Ah battery, the high-efficiency brushless motor further enhances efficiency, operating at optimal speeds of revolutions per minute (RPM) to ensure precise grass cutting. This combination of a high-capacity battery and a high- efficiency brushless motor contributes to the REVOLA's effectiveness in maintaining lawns while maximizing battery life.
5. Smart Connectivity: Smart Connectivity is a key aspect of the REVOLA, providing users with remote control and monitoring capabilities. The mower is equipped with Bluetooth, 4G, and Wi-Fi connectivity, ensuring comprehensive network coverage. Users can leverage the dedicated app to monitor the mower's progress from anywhere, allowing for real-time tracking of mowing activities. This connectivity not only enhances user convenience but also allows for more personalized and efficient lawn care based on specific preferences and needs.
6. RGB Recognition: RGB recognition in the REVOLA involves the use of Red, Green, and Blue color channels to identify and differentiate various elements within the lawn. The mower employs a sophisticated camera that captures images of the lawn. By analyzing the color spectrum and structure of the grass, the REVOLA can distinguish between different types of vegetation, ensuring a more targeted and efficient mowing process. This feature allows the mower to adapt its mowing pattern based on the specific characteristics of the lawn, resulting in a more precise and customized cutting experience.
7. OTA (Over the Air) Updates: The OTA update capability of the REVOLA enables the mower to receive software updates and enhancements remotely, without requiring manual intervention. This feature ensures that the REVOLA remains current with the latest technological developments, performance optimizations, and bug fixes. Manufacturers can regularly release updates to improve the mower's functionality, address any identified issues, or introduce new features. Users can conveniently download and install these updates over the air, ensuring that their REVOLA mower continues to operate at its best without the need for physical updates or visits to a service center.
Future Outlook and Industry Impact:
As the OPE market continues to evolve, the REVOLA robot lawn mower positions itself as a revolutionary product. Its advanced VSLAM technology, coupled with a user-friendly design, addresses longstanding industry challenges and paves the way for the future of intelligent lawn management. Yard Force's commitment to innovation and excellence sets the REVOLA apart, making it a frontrunner in reshaping the landscape of outdoor power equipment.
About Yard Force:
Yard Force is a world recognized brand dedicated to providing innovative outdoor power equipment solutions. With a focus on cutting-edge technology and user-friendly designs, Yard Force aims to transform the lawn care experience for users worldwide.
Follow Yard Force:
- Website: https://www.yardforce.eu
- Facebook: https://www.facebook.com/YardForceEurope
*Note: The information provided in this press release is based on data available as of Jan 23rd, 2024. Any future developments or changes may not be reflected in this release. *
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240130520868/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 08:10:00 CEST | Press release
AI-native operations model enables enterprises to move from reactive service delivery to intelligent, outcome-driven managed services LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across sys
Azafaros to Present at BIO International Convention 202615.6.2026 07:00:00 CEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press release
Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integrati
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom